Pharmaceutical Preparation Manufacturing - Market Size, Financial Statistics, Industry Trends

Industry Overview

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--
Source: U.S. Census Bureau

Pharmaceutical Preparation Manufacturing Market Size

This report includes historical and forecasted market sizes and industry trends for Pharmaceutical Preparation Manufacturing. It reveals overall market dynamics from 2020 through the present, and predicts industry growth or shrinkage through 2030. Revenue data include both public and private companies in the Pharmaceutical Preparation Manufacturing industry.

Historical Forecasted
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Market Size (Total Revenue)

Included in Report

% Growth Rate
Number of Companies
Total Employees
Average Revenue per Company
Average Employees per Company
Source: U.S. government financial data

Industry Revenue ($ Billions)

Pharmaceutical Preparation Manufacturing Industry Market Size
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022
  • 2023
  • 2024

Industry Forecast ($ Billions)

Pharmaceutical Preparation Manufacturing Industry Forecast
  • 2024
  • 2025
  • 2026
  • 2027
  • 2028
  • 2029
  • 2030


Pell Research's advanced econometric models forecast five years of industry growth based on short- and long-term trend analysis. Market size statistics include revenue generated from all products and services sold within the Pharmaceutical Preparation Manufacturing industry.

Geographic Breakdown by U.S. State

Pharmaceutical Preparation Manufacturing market share by state pinpoints local opportunities based on regional revenue statistics. Growth rate for each state is affected by regional economic conditions. Data by state can be used to locate profitable and nonprofitable locations for Pharmaceutical Preparation Manufacturing companies in the United States.

Industry Revenue by State [Sample]

Market Size by State

Distribution by Company Size

Company Size All Industries Pharmaceutical Preparation Manufacturing
Small Business (< 5 Employees)

Included

Small Business (5 - 20)
Midsized Business (20 - 100)
Large Business (100 - 500)
Enterprise (> 500)

Industry Income Statement (Average Financial Metrics)

Financial statement analysis determines averages for the following industry forces:
The report includes a traditional income statement from an "average" Pharmaceutical Preparation Manufacturing company (both public and private companies are included).

Industry Average Percent of Sales
Total Revenue

Included

Operating Revenue
Cost of Goods Sold (COGS)
Gross Profit
Operating Expenses
Operating Income
Non-Operating Income
Earnings Before Interest and Taxes (EBIT)
Interest Expense
Earnings Before Taxes
Income Tax
Net Profit


Average Income Statement

Average Income Statement

Cost of Goods Sold

Salaries, Wages, and Benefits

Rent

Advertising

Depreciation and Amortization

Officer Compensation

Net Income


Financial Ratio Analysis

Financial ratios allow a company's performance to be compared against that of its peers.

Financial RatioIndustry Average
Profitability Ratios

Included

Profit Margin
ROE
ROA
Liquidity Ratios
Current Ratio
Quick Ratio
Activity Ratios
Average Collection Period
Asset Turnover Ratio
Receivables Turnover Ratio
Inventory Conversion Ratio

Products and Services Mix

Product lines and services in the Pharmaceutical Preparation Manufacturing industry accounting for the largest revenue sources.

Product Description Description Revenue
($ Millions)

Pharmaceutical preparation manufacturing

Included

Affecting neoplams, endocrine system, & metabolic diseases

Acting on the central nervous system and the sense organs

Acting on the cardiovascular system, for human use

Acting on the respiratory system, for human use

Acting on the digestive/genito-urinary systems, for human use

Pharmaceutical preparations, acting on skin, for human use

Vitamin, nutrient, and hematinic preparations, for human use

Affecting parasitic and inefective diseases, for human use

Veterinary use, incl. medicinal premixes/pet care products


Compensation and Salary Surveys

Salary information for employees working in the Pharmaceutical Preparation Manufacturing industry.

TitlePercent of Workforce Bottom Quartile Average (Median) Salary Upper Quartile
Management Occupations 11%

Included

Chief Executives 0%
General and Operations Managers 2%
Business and Financial Operations Occupations 8%
Business Operations Specialists 7%
Architecture and Engineering Occupations 6%
Life, Physical, and Social Science Occupations 16%
Life Scientists 6%
Physical Scientists 6%
Chemists and Materials Scientists 6%
Chemists 6%
Office and Administrative Support Occupations 8%
Production Occupations 32%
Other Production Occupations 26%
Packaging and Filling Machine Operators and Tenders 9%
Packaging and Filling Machine Operators and Tenders 9%

Government Contracts

The federal government spent an annual total of $9,954,982,261 on the Pharmaceutical Preparation Manufacturing industry. It has awarded 14,814 contracts to 370 companies, with an average value of $26,905,357 per company.

Top Companies in Pharmaceutical Preparation Manufacturing and Adjacent Industries

Company Address Revenue
($ Millions)

Included